5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.66▲ | 3.63▲ | 3.63▲ | 3.74▼ | 3.82▼ |
MA10 | 3.64▲ | 3.61▲ | 3.64▲ | 3.89▼ | 3.81▼ |
MA20 | 3.61▲ | 3.64▲ | 3.72▼ | 3.86▼ | 3.60▲ |
MA50 | 3.66▲ | 3.72▼ | 3.85▼ | 3.78▼ | 3.54▲ |
MA100 | 3.73▼ | 3.88▼ | 3.94▼ | 3.61▲ | 3.54▲ |
MA200 | 3.82▼ | 3.91▼ | 3.90▼ | 3.73▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.013▲ | 0.009▲ | 0.004▲ | -0.048▼ | 0.031▲ |
RSI | 54.794▲ | 50.267▲ | 46.922▼ | 43.757▼ | 49.719▼ |
STOCH | 84.028▲ | 72.112 | 51.993 | 31.095 | 43.192 |
WILL %R | -8.333▲ | -26.667 | -42.105 | -73.750 | -67.424 |
CCI | 103.135▲ | 65.516 | 25.774 | -166.308▼ | -17.296 |
Monday, February 22, 2021 10:30 AM
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous sys ...
|
Monday, February 22, 2021 07:51 AM
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that company ...
|
Monday, February 22, 2021 05:46 AM
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that company ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/02/21 | 3.64 | 3.71 | 3.45 | 3.66 | 312,359 |
25/02/21 | 3.85 | 3.8597 | 3.55 | 3.61 | 441,776 |
24/02/21 | 3.78 | 3.98 | 3.755 | 3.80 | 325,682 |
23/02/21 | 3.80 | 3.87 | 3.50 | 3.71 | 924,758 |
22/02/21 | 4.09 | 4.09 | 3.86 | 3.90 | 428,210 |
19/02/21 | 4.04 | 4.25 | 4.03 | 4.11 | 523,799 |
18/02/21 | 4.00 | 4.09 | 3.91 | 4.01 | 510,088 |
17/02/21 | 4.11 | 4.11 | 3.86 | 4.09 | 373,622 |
16/02/21 | 4.13 | 4.22 | 3.94 | 4.06 | 670,152 |
12/02/21 | 3.95 | 4.03 | 3.8495 | 3.95 | 389,449 |
|
|
||||
|
|
||||
|
|